MS10612
|
IASp |
Iron Age |
Spain |
U |
-300 |
-200 |
H3+152 |
fasta
|
40.65
|
|
FASTA
Metadata
|
|
|
MS10613
|
IASp |
Iron Age |
Spain |
U |
-400 |
-400 |
U4a |
fasta
|
5.62
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
MS10614
|
IASp |
Iron Age |
Spain |
U |
-361 |
-178 |
T2b |
fasta
|
139.57
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
MS10617
|
IASp |
Iron Age |
Spain |
U |
-500 |
-400 |
U5b3 |
fasta
|
12.04
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
-
228A (MT-CR): Low VO2max response (Reported)
|
MS10619
|
IASp |
Iron Age |
Spain |
U |
-500 |
-400 |
H1c |
fasta
|
17.48
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
MS10620
|
IASp |
Iron Age |
Spain |
U |
-400 |
-400 |
J1c3g |
fasta
|
3.87
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
185A (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
-
9071T (MT-ATP6): Potentially functional variant cosegregating with LHON3635A (Reported)
|
MS10589
|
CASp |
Copper Age |
Spain |
U |
-900 |
-750 |
K1a1b1 |
fasta
|
3.55
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
114T (MT-CR): BD-associated (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
MS10622
|
IASp |
Iron Age |
Spain |
U |
-400 |
-400 |
H3 |
fasta
|
29.36
|
|
FASTA
Metadata
|
|
-
14577C (MT-ND6): MIDM (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
|